Inventor · disambiguated record
David R. Phillips
Also filed as: PHILLIPS DAVID · PHILLIPS DAVID R · PHILLIPS DAVID R III · PHILLIPS III DAVID R
28 granted patents·29 pending applications·329 citations·filing 1993–2025
97Inventor score
Files withWRIGLEY W M JUN CO17PORTOLA PHARM INC10COR THERAPEUTICS INC8ALEXION PHARMA INC2ANDRE PATRICK2
Top patents by PatentIndex Score
57 records- 0197US8153590B2Antidotes for factor Xa inhibitors and methods of using the sameLU GENMIN·Filed 2008·Granted Apr 10, 2012·56 cites·18 claims
- 0295US9388401B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Granted Jul 12, 2016·18 cites·19 claims
- 0395US9062298B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Jun 23, 2015·21 cites·18 claims
- 0495US8889129B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Nov 18, 2014·18 cites·22 claims
- 0595US8455441B2Antidotes for factor Xa inhibitors and methods of using the sameLU GENMIN·Filed 2012·Granted Jun 4, 2013·27 cites·18 claims
- 0693US6986907B2Chewing gum base and chewing gum compositionsWRIGLEY W M JUN CO·Filed 2003·Granted Jan 17, 2006·61 cites·83 claims
- 0791US10675335B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Granted Jun 9, 2020·3 cites·3 claims
- 0890US7358091B2Device and methods for identifying and treating aspirin non-responsive patientsPORTOLA PHARM INC·Filed 2005·Granted Apr 15, 2008·23 cites·14 claims
- 0988US2024082367A1Antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 1086US11839646B2Antidotes for factor Xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2020·Granted Dec 12, 2023·1 cites·12 claims
- 1184US7785891B2Device and methods for identifying and treating aspirin non-responsive patientsPORTOLA PHARM INC·Filed 2008·Granted Aug 31, 2010·10 cites·11 claims
- 1283US10737874B2Multi-piece dispenser for use with a consumable productWRIGLEY W M JUN CO·Filed 2016·Granted Aug 11, 2020·7 cites·19 claims
- 1382US10736335B2Chewing gum compositions based on dried fruit powdersWRIGLEY W M JUN CO·Filed 2012·Granted Aug 11, 2020·1 cites·10 claims
- 1479US6322990B1Methods of identifying agents that block the interaction of a BAP protein with a signaling partnerFiled 2000·Granted Nov 27, 2001·4 cites·4 claims
- 1578US9848619B2Chewing gums and gum bases comprising block copolymers having crystallizable hard blocksWRIGLEY W M JUN CO·Filed 2013·Granted Dec 26, 2017·1 cites·14 claims
- 1676US2025324998A1Molded confectionery products and methods of making sameWRIGLEY W M JUN CO·Filed 2025·Application pending·0 cites
- 1774US2021177001A1Molded confectionery products and methods of making sameWRIGLEY W M JUN CO·Filed 2019·Application pending·0 cites
- 1873US2024381895A1Fruit-containing confectionsWRIGLEY W M JUN CO·Filed 2022·Application pending·0 cites
- 1971US8057815B2Methods of treatment with Syk inhibitorsANDRE PATRICK·Filed 2005·Granted Nov 15, 2011·2 cites·13 claims
- 2071US7271152B2Compounds and methods for the modulation of CD154CBR INST FOR BIOMEDICAL RES·Filed 2002·Granted Sep 18, 2007·11 cites·44 claims
- 2168US6005089APlatelet glycoprotein V gene and usesCOR THERAPEUTICS INC·Filed 1996·Granted Dec 21, 1999·27 cites·16 claims
- 2264US6861504B2Compounds and methods for the modulation of CD154CBR INC·Filed 2001·Granted Mar 1, 2005·3 cites·7 claims
- 2364US2017156365A1Deposited chewing gum productWRIGLEY W M JUN CO·Filed 2014·Application pending·0 cites
- 2462US11653668B2Gum bases incorporating polymers derived from Russian DandelionWRIGLEY W M JUN CO·Filed 2017·Granted May 23, 2023·0 cites·17 claims
- 2562US2011171342A1Confectionery products providing an increased hydration sensationPHILLIPS III DAVID R·Filed 2009·Application pending·0 cites
- 2662US2023165269A1Chewable matrix and use thereof for the collection of saliva samples and infection detectionWRIGLEY W M JUN CO·Filed 2021·Application pending·0 cites
- 2760US2023047917A1Medium-chain-length polyhydroxyalkanoates and their use in chewing gum basesWRIGLEY W M JUN CO·Filed 2020·Application pending·0 cites
- 2859US2008241233A1Targeted delivery and expression of procoagulant hemostatic activityPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 2959US2009202673A1Chewing gum productsWRIGLEY W M JUN CO·Filed 2007·Application pending·0 cites
- 3057US2009048216A1Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitorPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 3157US2002164698A1Identification of Bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transductionCOR THERAPEUTICS INC·Filed 2001·Application pending·0 cites
- 3255US2009012136A1Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonistsPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 3355US2003135036A1Platelet glycoprotein v gene and usesCOR THERAPEUTICS INC A CORP OF·Filed 2002·Application pending·0 cites
- 3455US2009012115A1Use of tp modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populationsPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 3554US2005112234A1Environmentally friendly chewing gums including lecithinFiled 2004·Application pending·0 cites
- 3654US2012009172A1Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitorGRETLER DANIEL D·Filed 2011·Application pending·0 cites
- 3754US2018325139A1Chewing gum with natural elastomer or natural elastomer system and edible additiveWRIGLEY W M JUN CO·Filed 2016·Application pending·0 cites
- 3851US6194557B1Nucleic acid molecules encoding Bap-1 proteinsCOR THERAPEUTICS INC·Filed 1996·Granted Feb 27, 2001·9 cites·16 claims
- 3951US2004048803A1Compounds and methods for the modulation of CD154Filed 2003·Application pending·0 cites
- 4050US6953874B2Transgenic animals having a modified glycoprotein V geneMILLENNIUM PHARM INC·Filed 2001·Granted Oct 11, 2005·0 cites·11 claims
- 4149US6083688APlatelet glycoprotein V gene and usesCOR THERAPEUTICS INC·Filed 1994·Granted Jul 4, 2000·11 cites·12 claims
- 4248US11193919B2Methods for identifying carbon derived from natural sourcesWRIGLEY W M JUN CO·Filed 2016·Granted Dec 7, 2021·0 cites·13 claims
- 4348US6210913B1Modulation of integrin-mediated signal transductionCOR THERAPEUTICS INC·Filed 1996·Granted Apr 3, 2001·9 cites·7 claims
- 4447US8470357B2Methods of treatment with Syk inhibitorsANDRE PATRICK·Filed 2011·Granted Jun 25, 2013·0 cites·11 claims
- 4546US2012269924A1Chewing gums having improved removability based on linear viscoelastic shear rheologyPHILLIPS DAVID·Filed 2010·Application pending·0 cites
- 4646US2016143316A1Chewing gums having improved removability based on extensional flow propertiesWRIGLEY W M JUN CO·Filed 2016·Application pending·0 cites
- 4746US2012237632A1Chewing gums having improved removability based on extensional flow propertiesPHILLIPS DAVID·Filed 2010·Application pending·0 cites
- 4845US2010279409A1Method for modifying celluar immune resonse by modulating activin activityROBSON NEIL·Filed 2008·Application pending·0 cites
- 4944US2018184681A1Gum bases from renewable sourcesWRIGLEY W M JUN CO·Filed 2016·Application pending·0 cites
- 5043US2022322694A1Polyol-containing chewing gum basesWRIGLEY W M JUN CO·Filed 2020·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David R. Phillips files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →